By Laura Lutz
Des Moines, Sept. 5 - Life Therapeutics wrapped a private placement of shares for A$5.044 million.
The company sold 3,152,500 shares for A$1.60 each to domestic and international institutions.
The placement price was a 5% discount to the A$1.68 closing price on Aug. 31 and a 1.4% discount to the 30 trading day volume weighted average price of A$1.624.
The deal was managed by eG Capital.
The proceeds will be used to retire a convertible note and to open additional plasma collection centers.
Life Therapeutics, a biotechnology company focused on plasma-derived products, is based in Frenchs Forest, New South Wales, Australia.
| Issuer: | Life Therapeutics
|
| Issue: | Stock
|
| Amount: | A$5.044 million
|
| Shares: | 3,152,500
|
| Price: | A$1.60
|
| Warrants: | No
|
| Manager: | eG Capital
|
| Settlement date: | Sept. 5
|
| Stock symbol: | Australia: LFE
|
| Stock price: | A$1.63 at close on Sept. 5
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
